Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000246432

Medchemexpress LLC N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine | 443913-73-3 | MFCD07772346 | >98.0% | 475.35 g·mol⁻¹ | C22H24BrFN4O2 | 500 MG
SDP

Catalog No. 5000246432
Encompass_Preferred

Vandetanib is a small-molecule tyrosine kinase inhibitor used in oncology research to study angiogenesis and tumor cell signaling. It is supplied as a research-grade solid with analytical purity suitable for in vitro and preclinical studies.

  • Small-molecule tyrosine kinase inhibitor targeting VEGFR and EGFR.
  • Research-grade white to off-white powder suitable for laboratory use.
  • Typical purity ≥98.0% (HPLC).
  • Molecular weight 475.35 g·mol⁻¹; formula C22H24BrFN4O2.
  • Commonly supplied in 500 MG quantities for bench research.

Catalog No. 50-002-46432 Supplier Medchemexpress LLC Supplier No. HY10260500MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Vandetanib is a small-molecule tyrosine kinase inhibitor used in oncology research to study angiogenesis and tumor cell signaling. It is supplied as a research-grade solid with analytical purity suitable for in vitro and preclinical studies.

  • Small-molecule tyrosine kinase inhibitor targeting VEGFR and EGFR.
  • Research-grade white to off-white powder suitable for laboratory use.
  • Typical purity ≥98.0% (HPLC).
  • Molecular weight 475.35 g·mol⁻¹; formula C22H24BrFN4O2.
  • Commonly supplied in 500 MG quantities for bench research.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.